業績

• 2023年
• 2022年
• 2021年
• 2020年
• 2019年
• 2018年
• 2017年
• 2016年
• 2015年
• 2014年
• 2013年
• 2012年
• 2011年
• 2010年
• 2009年
• 2008年
• 2007年
• 2006年

2017年

• 原著
• 症例報告

原著

• Tanaka S, Ninomiya T, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Kitazono T, Tsuruya K.

  Impact of blood urea nitrogen to creatinine ratio on mortality and morbidity in hemodialysis patients: The Q-Cohort Study.

  Sci Rep 7 (1): 14901, 2017

• Hasegawa S, Nakano T, Torisu K, Tsuchimoto A, Eriguchi M, Haruyama N, Masutani K, Tsuruya K, Kitazono T.

  Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction.
  

  Lab Invest 97 (12): 1439-1452, 2017

• Tsuruya K, Torisu K, Yoshida H, Yamada S, Tanaka S, Tsuchimoto A, Eriguchi M, Fujisaki K, Masutani K, Kitazono T.

  Positive association of residual kidney function with hemoglobin level in patients on peritoneal dialysis independent of endogenous erythropoietin concentration.

  Ren Rep Ther 3: 47, 2017

• Matsukuma Y, Masutani K, Tanaka S, Tsuchimoto A, Haruyama N, Okabe Y, Nakamura M, Tsuruya K, Kitazono T.

  Association between serum uric acid level and renal arteriolar hyalinization in individuals without chronic kidney disease.

  Atherosclerosis 266: 121-127, 2017

• Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, Fujimoto S, Konta T, Moriyama T, Yamagata K, Narita I, Kimura K, Kondo M, Asahi K, Ohashi Y, Watanabe T.

  Association of hypertriglyceridemia with the incidence and progression of chronic kidney disease and modification of the association by daily alcohol consumption.

  J Ren Nutr 27 (6): 381-394, 2017

• Wakasugi M, Kazama J, Narita I, Iseki K, Fujimoto S, Moriyama T, Yamagata K, Konta T, Tsuruya K, Asahi K, Kondo M, Kurahashi I, Ohashi Y, Kimura K, Watanabe T.

  Association between overall lifestyle changes and the incidence of proteinuria: A population-based, cohort study.

  Intern Med 56 (12): 1475-1484, 2017

• Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T.

  Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population.

  PLoS One 12 (5): e0177779, 2017

• Katafuchi E, Nakayama M, Tanaka S, Sakoh T, Yoshitomi R, Fukui A, Seki M, Nakamata Y, Tominaga M, Tsuruya K, Kitazono T.

  Comparison of prognostic values of daytime and night-time systolic blood pressures on renal outcomes in patients with chronic kidney disease.

  Circ J 81 (10): 1454-1462, 2017

• Yamada S, Taniguchi M, Tokumoto M, Yoshitomi R, Yoshida H, Tatsumoto N, Hirakata H, Fujimi S, Kitazono T, Tsuruya K.

  Modified creatinine index and the risk of bone fracture in patients undergoing hemodialysis: the Q-Cohort Study.

  Am J Kidney Dis 70 (2): 270-280, 2017

• Matsumoto A, Nagasawa Y, Yamamoto R, Shinzawa M, Hasuike Y, Kuragano T, Isaka Y, Nakanishi T, Iseki K, Yamagata K, Tsuruya K, Yoshida H, Fujimoto S, Asahi K, Moriyama T, Watanabe T.

  The association of alcohol and smoking with CKD in a Japanese nationwide cross-sectional survey.

  Hypertens Res 40 (8): 771-778, 2017

• Iseki K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Konta T, Kasahara M, Shibagaki Y, Yoshida H, Moriyama T, Kondo M, Iseki C, Watanabe T; “Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Check”.

  Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.

  Clin Exp Nephrol 21 (6): 978-985, 2017

• Yotsueda R, Taniguchi M, Tanaka S, Eriguchi M, Fujisaki K, Torisu K, Masutani K, Hirakata H, Kitazono T, Tsuruya K.

  Cardiothoracic ratio and all-cause mortality and cardiovascular disease events in hemodialysis patients: the Q-Cohort Study.

  Am J Kidney Dis 70 (1): 84-92, 2017

• Tsuchimoto A, Nakano T, Hasegawa S, Masutani K, Matsukuma Y, Eriguchi M, Nagata M, Nishiki T, Kitada H, Tanaka M, Kitazono T, Tsuruya K.

  The potential role of perivascular lymphatic vessels in preservation of kidney allograft function.

  Clin Exp Nephrol 21 (4): 721-731, 2017

• Oka H, Yamada S, Kamimura T, Hara M, Hirashima Y, Matsueda S, Shukuri T, Aihara S, Koresawa M, Eriguchi M, Harada A, Tsuruya K, Kitazono T.

  Modified simple peritoneal wall anchor technique (PWAT) in peritoneal dialysis.

  Perit Dial Int 37 (1): 103-108, 2017

• Matsukuma Y, Masutani K, Tanaka S, Tsuchimoto A, Fujisaki K, Torisu K, Katafuchi R, Hirakata H, Tsuruya K, Kitazono T.

  A J-shaped association of serum uric acid level with poor renal survival in female patients with IgA nephropathy.

  Hypertens Res 40 (3): 291-297, 2017

• Kamei K, Konta T, Hirayama A, Ichikawa K, Kubota I, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Shibagaki Y, Kasahara M, Asahi K, Watanabe T.

  Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.

  Clin Exp Nephrol 21 (3): 497-503, 2017

• Masutani K, Tsuchimoto A, Kurihara K, Okabe Y, Kitada H, Okumi M, Tanabe K, Nakamura M, Kitazono T, Tsuruya K; Japan Academic Consortium of Kidney Transplantation (JACK) investigators.

  Histological analysis in ABO-compatible and ABO-incompatible kidney transplantation by performance of 3- and 12-month protocol biopsies.

  Transplantation 101 (6): 1416-1422, 2017

• Tsuruya K, Uemura Y, Hirakata H, Kitazono T, Tsubakihara Y, Suzuki M, Ohashi Y.

  Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: a pooled analysis of individual patient-level data from clinical trials.

  Nephrology (Carlton) 22: 769-775, 2017

• Nagae H, Tsuchimoto A, Tsuruya K, Kawahara S, Shimomura Y, Noguchi H, Masutani K, Katafuchi R, Kitazono T.

  Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.

  Clin Exp Nephrol 21 (2): 266-274, 2017

• Tanaka S, Ninomiya T, Fujisaki K, Yoshida H, Nagata M, Masutani K, Tokumoto M, Mitsuiki K, Hirakata H, Fujimi S, Kiyohara Y, Kitazono T, Tsuruya K; Fukuoka Kidney disease Registry (FKR) Study Collaboration Group.

  The Fukuoka Kidney disease Registry (FKR) study: design and methods.

  Clin Exp Nephrol 21 (3): 465-473, 2017

• Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Tatsumoto N, Ooboshi H, Kitazono T.

  Total phosphate elimination is negatively associated with increased serum FGF23 levels in patients who undergo peritoneal dialysis.

  Ther Apher Dial 21 (1): 71-78, 2017

症例報告

• Fujisaki K, Nakagawa K, Nagae H, Nakano T, Taniguchi M, Masutani K, Kitazono T, Tsuruya K.

  Asymptomatic Brain Edema after Hemodialysis Initiation in a Patient with Severe Uremia.

  Case Rep Med. 2017;2017:9265315.